ABSTRACT
INTRODUCTION
During last 2 decades, an epidemiologic transition has happened across the world, which is especially noticeable in developing countries, and has resulted in an obvious shift from communicable infectious diseases to chronic non-communicable diseases (NCD). [1] [2] [3] Similar shift has been observed among GILD.
Study of regional and national disease trend is an important and necessary step for priority setting in health research, and can help the authorities and policy makers to use the evidence based data for appropriate prevention and treatment of diseases. Data on trend of prevalence, incidence and mortality rates remain sparse especially in developing countries. In Iran the trends of infectious diseases have been reported periodically mainly by the Ministry of Health and trends of gastrointestinal cancers have been estimated mostly based on pathology based national cancer registries and a few population-based cancer registries in five provinces in Northern and Southern Iran (Golestan, Mazandaran, Gilan, Ardabil, and Kerman). As for other diseases in the category of GILD, the data are sparse and almost no population-based study at national level has been done on their trend. The Global Burden of Disease (GBD) study has been the first attempt to estimate the levels and trends of diseases at global, regional, and national level using novel and sophisticated statistical methods and unique metrics. [4] [5] [6] [7] [8] [9] [10] [11] [12] Details of methods reported elsewhere. 13, 14 In the present paper, we have investigated the results of GBD 2010 on the trend of GILD in Iran from 1990 to 2010.
MATERIALS AND METHODS
The details of major methods used in GBD for estimating deaths, years of life lost due to premature death (YLLs), years of life lost due to disability (YLDs), and disability adjusted life years (DALYs) have been adequately described elsewhere. 15 In the current paper, we investigated the trend of the above mentioned metrics for major gastrointestinal and hepatic diseases. Total numbers as well as age-standardized rates have been reported. The diseases studied in this paper included: infections of gastrointestinal tract (diarrhea, typhoid and paratyphoid fevers), acute hepatitis (A, B, C, and E), cancers of digestive system (esophagus, stomach, colon and rectum, liver, gall bladder. biliary tract and pancreas), end stage liver diseases (cirrhosis), and all other digestive diseases including: gastritis and duodenitis, peptic ulcer disease, appendicitis, paralytic ileus and intestinal obstruction without hernia, inguinal and femoral hernia, non-infective inflammatory bowel disease, vascular disorders of intestine, gall bladder and bile duct disease, pancreatitis, and yet other digestive diseases. The changes in ranking of these diseases in terms of their overall number as well as rates from 1990 to 2010 have been illustrated. Line trends of major gastrointestinal and hepatic diseases from 1990 to 1995, 2000, 2005 , and 2010 have been presented. Age-standardized rates have been reported to adjust for the effect of ageing and the population growth.
RESULTS
Tables 1 and 2 demonstrate the estimated age standardized rates of deaths and DALYs for 25 gastrointestinal and hepatic diseases in 1990, 2005, and 2010, separately for women and men in Iran. The death and DALY rates for most causes have decreased from 2005 to 2010 in both men and women. Exceptions are acute hepatitis B and C in women and acute hepatitis E and colorectal cancer in men. The percent changes of death rates from 2005 to 2010 range between -24.2% for gastritis and duodenitis and -23.4% for peptic ulcer to 16.0% for acute hepatitis C in women. As for men, the percent changes range from -22.1% for peptic ulcer to 1.6% for hepatitis E. The same pattern is observed for DALY rates. The percent changes of DALY rates from 2005 to 2010 range from -23.0% for peptic ulcer and -15.4% for gastritis and duodenitis to 10.0% for acute hepatitis C in women. As for men, the respective figures are -24.4% for peptic ulcer and 2.3% for acute hepatitis E.
The percent changes from 1990 to 2005 are much more significant. The most substantial decreases in death rates in both sexes are observed for diarrheal diseases, appendicitis, acute hepatitis A, gastritis and duodenitis, and gall bladder diseases. As for DALYs, diarrheal diseases, appendicitis, acute hepatitis A, gastritis and duodenitis, and cirrhosis due to causes other than hepatitis or alcohol are among the causes of DALYs with highest decrease in rate in both sexes. However, the decrease in acute hepatitis B in women is significant as well as gall bladder diseases in men.
The most substantial positive percent changes from 1990 to 2005 are observed for liver cancer, pancreatic cancer, and gall bladder cancer. The percent changes for both death and DALY rates for liver cancer and pancreatic cancer are over 100% in women. In men as well, the only observed positive percent changes belong to liver cancer, pancreatic cancer, and gall bladder cancer. Figure 1 demonstrates the ranking of diseases in terms of absolute number of deaths that they cause among females and males under 5 years. Results show that diarrheal diseases are still the main important cause of death in both sexes. The changes in rankings from 2005 to 2010 are not noteworthy. However, decreases are observed for acute hepatitis A and B, appendicitis, gastritis and duodenitis, gall bladder and bile duct diseases, cirrhosis secondary to hepatitis C, and pancreatitis in both sexes. Figure 2 shows the rankings of causes of death by numbers among women and men between 15 and 49 years of age. Similar to previous figure, changes in ranks are not noteworthy from 2005 to 2010. Stomach cancer, typhoid fevers, esophageal cancer, and colorectal cancer are the top 4 diseases in both years. However, the rankings show significant changes from 1990 to 2010. Increased ranks in terms of deaths numbers are observed for liver cancer secondary to hepatitis B, C and alcohol, as well as secondary to all other causes in women. Among men, increased ranks for liver cancers are less steep. Decreased ranks are observed for diarrheal diseases, appendicitis, gastritis and duodenitis, gall bladder diseases, pancreatitis, and all types of cirrhosis in both sexes. Figure 3 demonstrates the rankings of diseases Figure 4 shows the rankings of diseases in terms of age standardized DALY rates per 100,000 among women and men in 1990, 2005, and 2010. Stomach cancer, esophageal cancer, and colorectal cancer are the top 3 causes of DALY in 2005 and 2010 among both sexes. Liver cancers show increased ranks from 1990 to 2005. Diarrheal diseases and typhoid fevers, cirrhosis of all kinds, appendicitis, gastritis and duodenitis, gall bladder diseases, and pancreatitis have decreased ranks. Acute hepatitis A, B, and E show decreased ranks in oppose to the increased rank of hepatitis C in both sexes. The rank of peptic ulcer has not changed from 1990 to 2005 in men, but has a prominent increased rank in women. Figures 5, 6, 7 , and 8 show the trends of agestandardized rates from 1990 to 2010 for major GILD in both sexes in terms of DALYs, deaths, YLLs, and YLDs per 100,000 respectively. The trends in rates of DALYs, deaths, and YLLs are negative for almost all diseases, and especially for diarrheal diseases. Acute hepatitis B, stomach cancer, appendicitis, and cirrhosis show substantial decline. In spite of decreases in rates of DALYs, deaths, and YLLs, there is no upward or downward trend in rates of YLDs for most of diseases. Exceptions are gastritis and duodenitis, and peptic ulcer disease, which demonstrate a downward trend in terms of YLD rates.
Figures 9 and 10 show the trends of total DALYs and deaths for all ages both sexes. Unlike rates Sepanlou et al. 
Sepanlou et al.
and except for diarrheal diseases and appendicitis, trends are generally not declining. Total numbers of DALYs and deaths due to acute hepatitis C, stomach cancer, and liver cancers are rising. The total DALYs due to overall digestive diseases except cirrhosis and DALYs due to cirrhosis are not increasing and somehow stable. DISCUSSION GBD 2010 shows that compared with 1990 -the starting point of the first GBD study -the world's population has grown substantially older; that the main causes of disease burden have shifted from infectious diseases and childhood and maternal illnesses to non-communicable diseases such as coronary heart diseases and malignancies, and traffic injuries, 4, 9 and that now a significant portion of DALYs are attributed to disability rather than premature death. 5 Since 1990, the average length of a human life has increased substantially, but many people spend these extra years with chronic disabling diseases such as musculoskeletal disorders, major depression, cancers, or diabetes. 7, 8 In real life, one should consider life as a rectangle instead Acute hepatitis E Pancreatitis of a line, "length" of life is not the only measure to be considered to determine quality of life; "width" of life should also be considered! In Iran life expectancy has increased by 22 years for women and 21 years for men during last 45 years. 11 The incidence and mortality due to intestinal infections, mainly diarrheal diseases, typhoid and paratyphoid fevers, have decreased both among under 5 year children and adults (-40% decrease in years of life lost from 2000 to 2012). Similarly, trends of incidence and mortality rates of stomach cancer and esophageal cancer are declining in both men and women from 1975 to 2010. However, trends of colorectal cancer and liver cancer are stable or increasing in many countries during the same time period. All gastrointestinal and liver cancers have higher rates in men compared to women.
GBD 2010 study is a landmark study for assess- ing the trend of all diseases including GILD and their mortality and morbidity across the world and is a step forward in understanding changing risk factors of chronic diseases. In spite of being novel and very informative, this study has its own challenges especially in estimating the burden and trend of diseases in developing countries where data are of poor quality. Using population based local data from Iran, we will try to explain the challenges GBD 2010 faces and suggest strategies to improve the accuracy of future updates in GBD 2015.
Local studies in Iran imply that gastroesophageal reflux disease (GERD) and peptic ulcer disease, [16] [17] [18] [19] [20] [21] [22] irritable bowel syndrome (IBS), 17 inflammatory bowel diseases (IBD), [23] [24] [25] [26] [27] chronic nonalcoholic fatty liver disease (NAFLD), 28, 29 and chronic active and inactive HBV infection 30 are amongst the main causes of disability due to GILD in Iran. Among these common diseases, GERD, IBD, and NAFLD show a remarkable increasing trend during the recent decades. 22, 26, 29 However, these studies have their own limitations. Some of them are not population-based and others have reported outpatient or inpatient data of specific referral clinics or hospitals. This is the source of the challenge GBD faces in reporting those GILD that are detected in outpatient settings. This category of GI and hepatic diseases have not been adequately addressed and estimates even do not exist (eg. for the case of GERD and NAFLD) or seem to be lower than existing estimates (eg. for the case of Limited population based cancer registries established in Iran during last 2 decades confirm the findings of GBD 2010 and show an increasing trend for gastric and colorectal cancer and a declining trend of esophageal cancer. The reason for declining trend of squamous cell cancer of esophagus 31, 32 which seems to be paralleled by an increasing incidence of adenocarcinoma of esophagus 33 is most likely due to improvement is socioeconomic status of rural population in Iran and concomitant improvement in quality of nutrition. 34 Gastric cancer has remained as the most common cancer in Iran with no declining trend. 31, 35, 36 The reason for increasing prevalence of gastric cancer seems to be partly due to high H.pylori infection along with several important risk factors specifically common in Iranian population including tobacco, opium, poor oral health, high salt intake, and overweight and obesity. [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] A special characteristic of gastric cancer in Iran is the high incidence of proximal or so called cardia gastric cancer. 48, 49 Risk factors for gastric cardia cancer are obesity, overweight, and GERD which is becoming very common in Iran during last two decades. 49 Therefore, prevailing risk factors for non-cardia cancer along with addition of risk factors for gastric cardia cancer are probably the main reasons for the increasing incidence of gastric cancer in Iran. 41, 48 Despite the concordance of GBD results with population-based studies regarding gastric, esophageal, and colorectal cancers, the reported increasing trend of liver cancer seems to be overestimated. 31, 36, 50, 51 Primary liver cancer is not among the 10 most common cancers in Iran and majority of reported cases of liver cancer are actually metastatic secondary liver neoplasia with primary origin mainly from GI tract. 36, 51 HCV infection is very uncommon in Iran 52 and the HBV infection is of genotype D1 in more than 90% of cases. 30 For these reasons, liver cancer has been reported to be uncommon and there is no increasing trend reported from local studies and cancer registries during last 2 decades in Iran. 53, 54 It is evident that GBD has had numerous achievements since its establishment, including development of unique metrics for measurement of health across countries. The results have urged policymakers and other stakeholders especially in developing countries to identify priorities and take action for preventing the prevailing diseases and their risk factors at national level. However, cost-effective interventions may require more detailed and more accurate national and even sub-national estimates. In this regard, we have recently started an important study to especially investigate the trend of national and sub-national burden of gastrointestinal and liver diseases as part of national and sub-national burden of diseases (NASBOD) study in Iran. 55, 56 This study, which contains a comprehensive systematic review can be a reliable source to be used in future updates of GBD studies. Local gray literature, nonEnglish sources of data, access to micro-data of national surveys and specific sub-studies (on hospital data and prescriptions) will enrich the input data of NASBOD compared to GBD. The study can be adopted by other developing countries that are facing similar challenges.
